Henry Rodriguez

Henry Rodriguez

National Cancer Institute, National Institutes of Health
Deputy Director (Acting), Center for Strategic Scientific Initiatives; Director, Office of Cancer Clinical Proteomics Research

Henry Rodriguez, Ph.D, M.B.A., serves as the Deputy Director (Acting) of the Center for Strategic Scientific Initiatives, and is the founding Director of the Office of Cancer Clinical Proteomics Research, at the National Cancer Institute (NCI; Office of the Director), National Institutes of Health (NIH). Rodriguez also led the development of the International Cancer Proteogenome Consortium, and co-led the development of the Applied Proteogenomics OrganizationaL Learning and Outcomes network involving the DoD and VA healthcare system.

Dr. Rodriguez received his undergraduate degree in biology/chemistry and master’s degree in biology/toxicology from Florida International University. He went on to pursue his doctorate degree in cell and molecular biology from Boston University, and Master of Business Administration in finance and management from Johns Hopkins University. Fellowships were conducted at The Scripps Research Institute and at City of Hope National Medical Center.

Dr. Rodriguez serves on the U.S. HUPO Board of Directors, and the Foundation for the NIH Biomarkers Consortium Cancer Steering Committee. Dr. Rodriguez is the recipient of numerous honors, and serves on the editorial boards of Scientific Data, Clinical Proteomics, and Annals of Laboratory Medicine. Dr. Rodriguez has authored more than 129 original scientific papers, including co-editing a best-selling book on oxidative stress and aging.

Dr. Rodriguez has made important contributions to understanding mechanisms of cancer and age-related diseases, including development of molecular-based technologies in basic and translational science.